Drug Trial Radar · NCT02957786
Cytisine Versus Varenicline for Smoking Cessation
Last checked: Nov 20, 2026Latest source record: Aug 19, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
679
Actual
Start
Sep 18, 2017
Primary completion
Oct 10, 2019
Study completion Oct 10, 2019
Sponsor
- Lead sponsor
- University of Auckland, New ZealandAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Lakes District Health Board; Brunel University
- First posted
- Nov 8, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To evaluate the effectiveness, safety, and cost-effectiveness of cytisine plus behavioural support compared to varenicline plus behavioural support for smoking cessation, in indigenous Māori (or family of Māori) who smoke and are motivated to quit.
Conditions
- Smoking Cessation
Interventions
CytisineDrug
Cytisine tablets
Behavioural supportBehavioral
Withdrawal-orientated cessation support
VareniclineDrug
Varenicline tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Continuous abstinence from smokingTime frame: Six months post-quit date
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Institute for Health Innovation, University of Auckland
Auckland, North Island, New Zealand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.